HomeBLACU • NASDAQ
add
Bellevue Life Sciences Acquisition Units
Previous close
$10.95
Year range
$10.09 - $12.00
Market cap
44.09M USD
Avg Volume
174.00
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 475.54K | 69.67% |
Net income | -97.30K | -132.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -869.17% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 119.12K | 9,986.03% |
Total assets | 20.63M | -71.14% |
Total liabilities | 25.54M | -65.30% |
Total equity | -4.90M | — |
Shares outstanding | 4.04M | — |
Price to book | -9.05 | — |
Return on assets | -4.11% | — |
Return on capital | 32.16% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -97.30K | -132.27% |
Cash from operations | -1.42M | -307.45% |
Cash from investing | 17.20M | — |
Cash from financing | -15.67M | — |
Net change in cash | 115.48K | 133.22% |
Free cash flow | -980.34K | -6,925.48% |
About
Founded
2020
Headquarters
Website
